FDA Approves BRINSUPRI for Non-Cystic Fibrosis Bronchiectasis Treatment
August 13, 2025
Approximately 500,000 U.S. Patients Are Diagnosed with Non-Cystic Fibrosis Bronchiectasis (NCFB), a Progressive Disease That Can Lead to Permanent Lung DamageInsmed Incorporated, a global biopharmaceutical